Merck’s (NYSE:MRK) monoclonal antibody clesrovimab, designed as a prophylactic against respiratory syncytial virus (RSV), has ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

Rising cases of severe respiratory syncytial virus (RSV) in kids show new warning signs, highlighting the need for increased ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and pregnant women. It leads to symptoms ranging from mild colds to severe ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

Flu, COVID-19 and RSV are predicted to cause about as many hospitalizations as last year. Houston experts offer tips for ...

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...

GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV ...

For the next few months, cases of COVID-19, flu and respiratory syncytial virus, or RSV, are expected to rise as people gather indoors for the holidays. Infectious disease experts say October is ...

A team of researchers has identified signs tied to more severe cases of respiratory syncytial virus (RSV) in children.